Form 8-K - Current report:
SEC Accession No. 0000874716-24-000142
Filing Date
2024-11-06
Accepted
2024-11-06 16:00:19
Documents
15
Period of Report
2024-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20241031.htm   iXBRL 8-K 28426
6 idxx-20241031_g1.jpg GRAPHIC 47794
  Complete submission text file 0000874716-24-000142.txt   291764

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20241031.xsd EX-101.SCH 2127
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20241031_def.xml EX-101.DEF 14941
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20241031_lab.xml EX-101.LAB 26357
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20241031_pre.xml EX-101.PRE 15589
18 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20241031_htm.xml XML 2863
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 241430744
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)